摘要:
Compounds of the formula and their pharmaceutically acceptable salts, wherein the substituents are as defined herein, having antihypertensive activity.
摘要:
The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
摘要:
A method of producing 1,2,4-benzothiadiazine-1,1-dioxide compound of formula (I), including reacting a 2-aminobenzenesulfonamide compound with a 1,1-dialkoxyalkene compound or with an orthoester compound, in the presence of an acid, to obtain an iminoether compound, and then subjecting the iminoether compound to a ring closure reaction, in the presence of a base: wherein, in formula (I), R 1 is an alkyl group, or an aryl group; R 2 is a substituent; n is 0 to 4; and R 3 is a hydrogen atom or a substituent.
摘要:
The invention describes novel compositions and kits comprising at least one nitric oxide enhancing diuretic compound, or pharmaceutically acceptable salts thereof, and, optionally, at least one nitric oxide enhancing compound and/or at least one therapeutic agent. The invention also provides methods for (a) treating conditions resulting from excessive water and/or electrolyte retention; (b) treating cardiovascular diseases; (c) treating renovascular diseases; (d) treating diabetes; (e) treating diseases resulting from oxidative stress; (f) treating endothelial dysfunctions; (g) treating diseases caused by endothelial dysfunctions; (h) treating cirrhosis; (j) treating pre-eclampsia; (k) treating osteoporosis; (1) treating nephropathy; (m) treating peripheral vascular diseases; (n) treating portal hypertension; (o) treating central nervous system disorders; (p) treating metabolic syndrome; (q) treating sexual dysfunctions; and (r) hyperlipidemia. The nitric oxide enhancing diuretic compounds comprise at least one nitric oxide enhancing group linked to the diuretic compound through one or more sites such as carbon, oxygen and/or nitrogen via a bond or moiety that cannot be hydrolyzed.
摘要:
Verbindungen der Formel (die Bedeutung der Symbole ist in der Beschreibung erläutert) können nach an sich bekannten Verfahren hergestellt und als Arzneistoffe verwendet werden.
摘要:
Die neuen Verbindungen der Formel (die Definitionen der einzelnen Reste sind in der Beschreibung aufgeführt) können nach konventionellen Methoden hergestellt werden. Die Verbindungen eignen sich zur Behandlung und Prophylaxe des Bluthochdrucks.
摘要:
Compounds of the formula and their pharmaceutically acceptable salts, wherein the substituents are as defined herein, having antihypertensive activity.